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BACKGROUND

AN APPROACH TO ANTIEPILETICS IN HOSPICE

Seizures are commonly seen in patients with brain
mets.
- Dysphagia can negatively impact seizure control.
- Hospice formularies may limit coverage of AEDs.
OBJECTIVE
We propose an approach to antiepiletics in hospice that
includes the evaluation of steroids, medication options,
pharmacy consultation and seizure breakthrough plan
so that we meet the goals of the patient on hospice.

•Pros: Reduce
vasogenic edema,
improve appetite
•Cons: assoc. with
psychosis, delirium,
insomnia

Eval for Steroids
(Dexamethasone)

Medication
Options
•Dysphagia & mental
status assessments
•Pharmacy consult
for barriers to med
of choice

CASE DESCRIPTION
63yo F with focal motor R sided seizures secondary to
endometrial mets to the brain s/p L parietal crani.
- She developed difficulty swallowing and was noted
to have increased seizure like activity.

ALTERNATIVE MEDICATION ADMINISTRATION ROUTES
Route
IV

- The patient wished to transition to home hospice.
- Her seizure regimen changed: d/c Zonisamide due to
coverage concerns and change to liquid Keppra.
- She was started on Decadron and Ativan Intensol
sublingual solution as needed for seizure.
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DISCUSSION
Dysphagia is common in patients with brain metastases
at the end of life.
- Alternate routes include intranasal, rectal,
transdermal, transmucosal, subcutaneous, and IV.
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Solutions

- Knowing which drugs are routinely covered by a
hospice can help guide a patient’s seizure
management at the end of life.
- We present a guide for providers in choosing antiepileptic regimens for patients on hospice programs.
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Medication Options
Phenytoin, Levetiracetam,
Phenobarbital, Valproic
Acid, Acetazolamide,
Brivaracetam, Midazolam,
Diazepam, Lorazepam
Phenobarbital, Midazolam,
Lorazepam
Levetiracetam,
Clonazepam, Lamotrigine,
Clobazam (oral film)
Phenytoin, Carbamazepine,
Levetiracetam, Vigabatrin,
Lamotrigine, Perampanel,
Brivaracetam
Phenytoin, Carbamazepine,
Oxcarbamazepine,
Clobazam Lacosamide,
Levetiracetam
Diazepam
Midazolam
Valproic Acid

•Discuss with patient
and caregiver level
of comfort for giving
breakthrough med
and by which route

Breakthrough
Plan

Patient Goal
•Weigh side effects
of meds with patient
and goals
•Assess if inpatient is
needed for
palliative sedation

